Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation

Journal of Biological Chemistry

Volumn 287, Issue 21, 2012, Pages 17109-17119

  Chen, Hongyan ^a   Yuan, Yi ^a   Zhang, Chunpeng ^a   Luo, Aiping ^a   Ding, Fang ^a   Ma, Jianlin ^a   Yang, Shouhui ^a   Tian, Yanyan ^a   Tong, Tong ^a   Zhan, Qimin ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL ASSAY; CELL INVASION; CELL MOTILITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVER-EXPRESSION; HUMAN BREAST CANCER; INVASIVENESS; MATRIX METALLOPROTEINASES; MRNA EXPRESSION; OVER-EXPRESSION; PCR ANALYSIS; TRANSCRIPTIONAL REGULATION; TUMORIGENESIS; UNDERLYING MECHANISM; WILD TYPES;

CELLS; GENES; PATHOLOGY; POLYMERASE CHAIN REACTION; PROTEINS; TRANSCRIPTION;

CYTOLOGY;

GELATINASE A; MESSENGER RNA; PROTEIN P53; PROTEIN S 100; S100A14 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861206778     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.326975     Document Type: Article

References (48)

1. Steeg, P. S. (2006) Tumor metastasis. Mechanistic insights and clinical challenges. Nat. Med. 12, 895-904
2. Gupta, G. P., and Massagué, J. (2006) Cancer metastasis. Building a framework. Cell 127, 679-695
3. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890
4. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumor progression. Nat. Rev Cancer 2, 442-454
5. Roy, R., Yang, J., and Moses, M. A. (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287-5297
6. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65 (Pubitemid 24216953)
7. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422 (Pubitemid 28232085)
8. Heizmann, C. W., Fritz, G., and Schafer, B. W. (2002) S100 proteins. Structure, functions, and pathology. Front. Biosci. 7, d1356-d1368
9. Boye, K., and Maelandsmo, G. M. (2010) S100A4 and metastasis. A small actor playing many roles. Am. J. Pathol. 176, 528-535
10. Hiratsuka, S., Watanabe, A., Aburatani, H., and Maru, Y. (2006) Tumor-mediated up-regulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375 (Pubitemid 44835111)
11. Saleem, M., Kweon, M. H., Johnson, J. J., Adhami, V. M., Elcheva, I., Khan, N., Bin Hafeez, B., Bhat, K. M., Sarfaraz, S., Reagan-Shaw, S., Spiegelman, V. S., Setaluri, V., and Mukhtar, H. (2006) S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc. Natl. Acad. Sci. U.S.A. 103, 14825-14830 (Pubitemid 44527813)
12. Moon, A., Yong, H. Y., Song, J. I., Cukovic, D., Salagrama, S., Kaplan, D., Putt, D., Kim, H., Dombkowski, A., and Kim, H. R. (2008) Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res. 6, 1544-1553
13. Pietas, A., Schlüns, K., Marenholz, I., Schäfer, B. W., Heizmann, C. W., and Petersen, I. (2002) Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 79, 513-522 (Pubitemid 34274292)
14. Jin, Q., Chen, H., Luo, A., Ding, F., and Liu, Z. (2011) S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One 6, e19375
15. Sapkota, D., Bruland, O., Costea, D. E., Haugen, H., Vasstrand, E. N., and Ibrahim, S. O. (2011) S100A14 regulates the invasive potential of oral squamous cell carcinoma-derived cell lines in vitro by modulating expression of matrix metalloproteinases MMP1 and MMP9. Eur. J. Cancer 47, 600-610
16. Sapkota, D., Costea, D. E., Blø, M., Bruland, O., Lorens, J. B., Vasstrand, E. N., and Ibrahim, S. O. (2012) S100A14 inhibits proliferation of oral carcinoma-derived cells through G1-arrest. Oral. Oncol. 48, 219-225
17. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008) Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 9, 402-412 (Pubitemid 351574202)
18. Sankpal, N. V., Willman, M. W., Fleming, T. P., Mayfield, J. D., and Gillanders, W. E. (2009) Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res. 69, 753-757
19. Hwang, C. I., Matoso, A., Corney, D. C., Flesken-Nikitin, A., Körner, S., Wang, W., Boccaccio, C., Thorgeirsson, S. S., Comoglio, P. M., Hermeking, H., and Nikitin, A. Y. (2011) Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc. Natl. Acad. Sci. U.S.A. 108, 14240-14245
20. Kruse, J. P., and Gu, W. (2009) Modes of p53 regulation. Cell 137, 609-622
21. Lin, J., Yang, Q., Yan, Z., Markowitz, J., Wilder, P. T., Carrier, F., and Weber, D. J. (2004) Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells. J. Biol. Chem. 279, 34071-34077 (Pubitemid 39063059)
22. Mueller, A., Schäfer, B. W., Ferrari, S., Weibel, M., Makek, M., Höchli, M., and Heizmann, C. W. (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem. 280, 29186-29193 (Pubitemid 41161370)
23. Grigorian, M., Andresen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., Cohn, M., Ambartsumian, N., Christensen, A., Selivanova, G., and Lukanidin, E. (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein. Functional consequences of their interaction. J. Biol. Chem. 276, 22699-22708
24. Zhang, C., Zhu, C., Chen, H., Li, L., Guo, L., Jiang, W., and Lu, S. H. (2010) Kif18A is involved in human breast carcinogenesis. Carcinogenesis 31, 1676-1684
25. Tian, Y., Luo, A., Cai, Y., Su, Q., Ding, F., Chen, H., and Liu, Z. (2010) MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 285, 7986-7994
26. Chen, H., Yu, D., Luo, A., Tan, W., Zhang, C., Zhao, D., Yang, M., Liu, J., Lin, D., and Liu, Z. (2009) Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res. 69, 3451-3457
27. Wang, Q., Li, W., Liu, X. S., Carroll, J. S., Jänne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J., and Brown, M. (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 27, 380-392 (Pubitemid 47126935)
28. Huang, S., and Ingber, D. E. (2000) Shape-dependent control of cell growth, differentiation, and apoptosis. Switching between attractors in cell regulatory networks. Exp. Cell Res. 261, 91-103
29. Pollard, T. D. (2003) The cytoskeleton, cellular motility, and the reductionist agenda. Nature 422, 741-745
30. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., and Seiki, M. (2001) Homophilic complex formation of MT1-MMP facilitates pro-MMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J. 20, 4782-4793 (Pubitemid 32848631)
31. Itoh, Y., Ito, A., Iwata, K., Tanzawa, K., Mori, Y., and Nagase, H. (1998) Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J. Biol. Chem. 273, 24360-24367 (Pubitemid 28454925)
32. Das, S., Boswell, S. A., Aaronson, S. A., and Lee, S. W. (2008) p53 promoter selection. Choosing between life and death. Cell Cycle 7, 154-157 (Pubitemid 351366513)
33. Menendez, D., Inga, A., and Resnick, M. A. (2009) The expanding universe of p53 targets. Nat. Rev. Cancer 9, 724-737
34. Vousden, K. H., and Prives, C. (2009) Blinded by the light. The growing complexity of p53. Cell 137, 413-431
35. Lavin, M. F., and Gueven, N. (2006) The complexity of p53 stabilization and activation. Cell Death Differ. 13, 941-950
36. Toschi, E., Rota, R., Antonini, A., Melillo, G., and Capogrossi, M. C. (2000) Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase- 2 levels in p53-mutated human melanoma cells. J. Invest. Dermatol. 114, 1188-1194 (Pubitemid 30415238)
37. Bian, J., and Sun, Y. (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol. 17, 6330-6338 (Pubitemid 27451177)
38. Fang, G., Yu, H., and Kirschner, M. W. (1998) Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol. Cell 2, 163-171 (Pubitemid 128373642)
39. Vlieghe, D., Sandelin, A., De Bleser, P. J., Vleminckx, K., Wasserman, W. W., van Roy, F., and Lenhard, B. (2006) A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res. 34, D95-D97
40. Liu, G., Xia, T., and Chen, X. (2003) The activation domains, the prolinerich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein. J. Biol. Chem. 278, 17557-17565 (Pubitemid 36799644)
41. Bulk, E., Sargin, B., Krug, U., Hascher, A., Jun, Y., Knop, M., Kerkhoff, C., Gerke, V., Liersch, R., Mesters, R. M., Hotfilder, M., Marra, A., Koschmieder, S., Dugas, M., Berdel, W. E., Serve, H., and Müller-Tidow, C. (2009) S100A2 induces metastasis in non-small cell lung cancer. Clin. Cancer Res. 15, 22-29
42. Wang, H. Y., Zhang, J. Y., Cui, J. T., Tan, X. H., Li, W. M., Gu, J., and Lu, Y. Y. (2010) Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol. Rep. 23, 45-52
43. Brooks, C. L., and Gu, W. (2006) p53 ubiquitination. Mdm2 and beyond. Mol. Cell 21, 307-315
44. Mehta, S. A., Christopherson, K. W., Bhat-Nakshatri, P., Goulet, R. J., Jr., Broxmeyer, H. E., Kopelovich, L., and Nakshatri, H. (2007) Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells. Implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene 26, 3329-3337 (Pubitemid 46788879)
45. Sun, Y., Sun, Y., Wenger, L., Rutter, J. L., Brinckerhoff, C. E., and Cheung, H. S. (1999) p53 down-regulates human matrix metalloproteinase-1 (Collagenase- 1) gene expression. J. Biol. Chem. 274, 11535-11540
46. Liu, J., Zhan, M., Hannay, J. A., Das, P., Bolshakov, S. V., Kotilingam, D., Yu, D., Lazar, A. F., Pollock, R. E., and Lev, D. (2006) Wild-type p53 inhibits nuclear factor-κB-induced matrix metalloproteinase-9 promoter activation. Implications for soft tissue sarcoma growth and metastasis. Mol. Cancer Res. 4, 803-810 (Pubitemid 44877010)
47. Sun, Y., Cheung, J. M., Martel-Pelletier, J., Pelletier, J. P., Wenger, L., Altman, R. D., Howell, D. S., and Cheung, H. S. (2000) Wild-type and mutant p53 differentially regulate the gene expression of human collagenase- 3 (hMMP-13). J. Biol. Chem. 275, 11327-11332 (Pubitemid 30212782)
48. Ho, J., and Benchimol, S. (2003) Transcriptional repression mediated by the p53 tumor suppressor. Cell Death Differ. 10, 404-408 (Pubitemid 36636906)